Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.980
+0.070 (2.41%)
Nov 18, 2026, 4:00 PM EST - Market closed
Galectin Therapeutics Employees
Galectin Therapeutics had 9 employees as of December 31, 2025. The number of employees decreased by 6 or 40.00% compared to the previous year. That makes Galectin Therapeutics the 40,497th largest employer in the world and 6,089th in the United States.
Employees
9
Change (1Y)
-6
Growth (1Y)
-40.00%
Revenue / Employee
n/a
Profits / Employee
-$2,596,889
Market Cap
300.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | -6 | -40.00% |
| Dec 31, 2024 | 15 | 1 | 7.14% |
| Dec 31, 2023 | 14 | 2 | 16.67% |
| Dec 31, 2022 | 12 | 3 | 33.33% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 231 |
| Nautilus Biotechnology | 128 |
| Inovio Pharmaceuticals | 112 |
| SAB Biotherapeutics | 86 |
| Agenus | 81 |
| AgomAb Therapeutics NV | 62 |
| X4 Pharmaceuticals | 45 |
| Benitec Biopharma | 24 |
GALT News
- 2 days ago - Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 days ago - Galectin Therapeutics Quarterly report: Q3 2026 - Filings
- 2 days ago - Galectin Therapeutics Earnings release: Q3 2026 - Filings
- 13 days ago - Galectin Therapeutics Presents New Analyses on Noninvasive Prediction of Variceal Development from its Belapectin Development Program at AASLD Liver Meeting 2026 - GlobeNewsWire
- 5 weeks ago - Galectin Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Galectin Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026 - GlobeNewsWire
- 6 weeks ago - Galectin Therapeutics Proxy statement: Proxy filing - Filings